In a study using two different methods of analysis, the preclinical detectable phase for open-angle glaucoma was estimated to be approximately 10 years, suggesting that a reasonable screening interval ...
Recent advances have uncovered therapeutic interventions that might reduce the risk of progression of premalignant diagnoses, such as monoclonal gammopathy of undetermined significance (MGUS) to ...
Worldwide debate about how often to screen patients for diabetes-related eye disease is given clarification in this week's issue of THE LANCET. A UK study which involved over 7500 patients provides an ...